Company Description
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States.
It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders.
Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
| Country | United States |
| Founded | 1995 |
| IPO Date | Jul 28, 2016 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 992 |
| CEO | Sheri Dodd |
Contact Details
Address: 3701 Wayzata Boulevard, Suite 300 Minneapolis, Minnesota 55416 United States | |
| Phone | 612 355 5100 |
| Website | tactilemedical.com |
Stock Details
| Ticker Symbol | TCMD |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001027838 |
| CUSIP Number | 87357P100 |
| ISIN Number | US87357P1003 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Sheri Louise Dodd | Chief Executive Officer and Director |
| Elaine M. Birkemeyer | Chief Financial Officer |
| Kristie T. Burns | Senior Vice President of Marketing and Clinical Affairs |
| Sherri Ferstler | Senior Vice President of Sales |
| Daniel L. Reuvers | Director and Advisor |
| Jerry A. Sauber | Senior Vice President of Manufacturing, Operations, Research & Development |
| John David Kaercher | Chief Information Officer |
| Sunday J. Hoy Esq. | Vice President of Regulatory Affairs and Chief Compliance Officer |
| Janelle M. Strop | Chief Human Resource Officer |
| Dr. Antonios P. Gasparis F.A.C.S., M.D. | Chief Medical Officer and Member of Vascular Strategic Advisory Board |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 13, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 8, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 4, 2024 | 10-Q | Quarterly Report |
| Nov 4, 2024 | 8-K | Current Report |
| Aug 12, 2024 | 144 | Filing |
| Aug 5, 2024 | 10-Q | Quarterly Report |
| Aug 5, 2024 | 8-K | Current Report |
| Jul 10, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jul 5, 2024 | 8-K | Current Report |